Twist Bioscience TWST
NASDAQ TWST
$155.40 +12.32 (+8.61%)
As of: Sep 17, 2026 · 3:59 PM EDT

Twist Bioscience (TWST) Restructuring Costs (2019 - 2026)

Twist Bioscience's (TWST) quarterly Restructuring Costs came in at $7.2 million in Q1 2026, up 2070.18% quarter-over-quarter from $332000.0 in Q3 2023.

Analysis

Twist Bioscience (TWST) Restructuring Costs (2019 - 2026) Analysis & Trends

Twist Bioscience (TWST) has reported Restructuring Costs for 3 consecutive years, with $7.2 million the latest figure, recorded in Q1 2026.

  • On a quarterly basis, Restructuring Costs changed N/A year-over-year to $7.2 million in Q1 2026; TTM through Jun 2026 was $7.2 million, a N/A change from a year earlier, with the FY2023 full-year figure at $9.4 million, changed N/A from the prior year.
  • Restructuring Costs was $7.2 million for Q1 2026 at Twist Bioscience, up from $332000.0 in the prior quarter.
  • Over five years, Restructuring Costs peaked at $9.1 million in Q2 2023 and troughed at $332000.0 in Q3 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn
10 Twist Bioscience 8.93 Bn 8.76 Bn 62.45 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 7.21 Mn
Sep 30, 2023 332,000.00
Jun 30, 2023 9.05 Mn
Dec 31, 2019 22.50 Mn